Science Explorer Back to mapMap
Discussion
Researcher · Dana-Farber Cancer Institute · United States

Charles S. Fuchs

Charles S. Fuchs publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes and Colorectal Cancer Screening and Detection.

ORCID 0000-0003-1582-9842 OpenAlex
World rank
#2,532
of 7,710,434 ranked researchers
Rank in United States
#917
of 1,627,098
Works
1,710
Citations
116k
Citations per work
67.6
h-index
173
i10-index 770Top 0.1% in Oncology
Charles S. Fuchs

What does Charles S. Fuchs research?

Charles S. Fuchs's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (14%).

Health Sciences: 853 works · 49.9% of their workMedicine: 853 works · 49.9% of their workOncology: 477 works · 27.9% of their workPulmonary and Respiratory Medicine: 144 works · 8.4% of their workPathology and Forensic Medicine: 116 works · 6.8% of their workSurgery: 116 works · 6.8% of their workEverything else: 609 works · 35.6% of their workLife Sciences: 248 works · 14.5% of their workBiochemistry, Genetics and Molecular Biology: 248 works · 14.5% of their workMolecular Biology: 156 works · 9.1% of their workCancer Research: 92 works · 5.4% of their workTHEIR WORKCharles S. Fuchs1,710works
Life Sciences14%Health Sciences50%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine85349.9%
  2. Everything else60935.6%
    1. Biochemistry, Genetics and Molecular Biology24814.5%
  1. 1Oncology28% of their works
  2. 2Molecular Biology9% of their works
  3. 3Pulmonary and Respiratory Medicine8% of their works
  4. 4Surgery7% of their works
  5. 5Pathology and Forensic Medicine7% of their works
  6. 6Cancer Research5% of their works

Research topics

Which keywords describe Charles S. Fuchs's research?

The keywords of their largest research topics: Chemotherapy, Molecular Characterization, Tumor Microenvironment, Cetuximab, KRAS Mutations, Endoscopic Resection, Gastric Cancer and Colorectal Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Chemotherapy5113 topics
  2. Molecular Characterization2952 topics
  3. Tumor Microenvironment2162 topics
  4. Cetuximab2151 topic
  5. KRAS Mutations2151 topic
  6. Endoscopic Resection1661 topic
  7. Gastric Cancer1661 topic
  8. Colorectal Cancer1611 topic
  9. Screening1611 topic
  10. Pancreatic Cancer1301 topic
  11. Surgical Complications1301 topic
  12. Hereditary Syndromes1291 topic
  13. Microsatellite Instability1291 topic
  14. Cardiovascular Disease971 topic
  15. Mediterranean Diet971 topic
  16. Immune Checkpoint Blockade861 topic
  17. PD-1 and PD-L1861 topic
  18. DNA Methylation721 topic
  19. Histone Modification721 topic

Where does Charles S. Fuchs work?

Charles S. Fuchs's main affiliation in the publication record is Dana-Farber Cancer Institute, United States.

How many publications and citations does Charles S. Fuchs have?

OpenAlex counts 1,710 works and 115,673 citations for Charles S. Fuchs, an h-index of 173, ranking #2,532 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Charles S. Fuchs. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.